Kenvue Inc. Common Stock (KVUE)

The company's baby powder product is under legal fire once again.

New York, NY – October 16, 2025 – The Consumer Staples and Healthcare sectors of the S&P 500 are experiencing a notable day of underperformance, largely overshadowed by the precipitous stock plunge of Kenvue (NYSE: KVUE). The consumer health giant, spun off from Johnson & Johnson (NYSE: JNJ), is grappling with a

New York, NY – October 16, 2025 – Johnson & Johnson (NYSE: JNJ), once considered a stalwart of stability, is currently navigating turbulent waters, finding itself among the market's bottom performers today. The precipitous drop in its stock is directly linked to an escalating barrage of talc-related lawsuits, including a staggering £1 billion

Kenvue (NYSE: KVUE), the consumer health giant spun off from Johnson & Johnson, has found itself at the bottom of today's market performance, with its stock price experiencing a significant decline. As of October 16, 2025, the company's shares are trending down by 10.3% and have marked a year-long decline

Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Thursday.

Curious about the most active S&P500 stocks in today's session? Get insights into the stocks that are leading the way in terms of trading volume and market attention.

Let's have a look at the top S&P500 gainers and losers in the middle of the day of today's session.

Johnson & Johnson faces 3,000 UK lawsuits alleging asbestos-contaminated talcum powder caused cancer and concealed risks for decades.

Meanwhile, analysts raised price targets on the stock following strong Q3 results and the planned orthopedic spin-off.

Juicy dividends are only part of the attraction with these beaten-down stocks.

Let's have a look at the top S&P500 gainers and losers one hour before the close of the markets of today's session.

Johnson & Johnson stock trades near all-time highs with an upcoming Q3 earnings report acting as the next catalyst.

KFF poll shows falling trust in the CDC and HHS chief RFK Jr. as misinformation and partisan divides shape public views on vaccines.

This company's short life on the stock market has been a constant challenge.

Curious about the top performers within the S&P500 index one hour before the close of the markets on Thursday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.

U.S. stocks edged lower on Thursday, pausing after a record-setting run. The S&P 500 slipped 0.4% by midday in New York, retreating from an all-time high of 5,674 hit at the open.

Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Thursday.

One of these stocks lost about a quarter of its value in a single month.

This beaten-down stock could be an attractive option for long-term investors.

Get insights into the S&P500 index performance on Tuesday. Explore the top gainers and losers within the S&P500 index in today's session.

Risk sentiment is taking a breather after days of a relentless rally, with all major Wall Street indexes trading in negative territory and sharper declines hitting the most speculative assets, such as cryptocurrencies.

Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Tuesday.

Investors are interested in this beaten-down business.

While Kenvue's Tylenol has attracted intense political pressure, speculators are determined to make KVUE stock great again.